Abstract
Background
Positive sentinel node biopsy or clinically/radiologically demonstrable lymph node metastases in patients with malignant melanoma establishes the indication for inguinal dissection. Currently the deep (pelvic) part of the dissection is the subject of lively discussion. For the past 3 years we have been carrying out all pelvic lymph node dissections using an endoscopic extraperitoneal approach in combination with conventional superficial inguinal dissection.
Methods
In analogy to endoscopic extraperitoneal hernia repair we open the extraperitoneal space with the aid of a dissection balloon and then perform a complete dissection of the para-iliac and obturator lymph nodes. The superficial part of inguinal dissection is then carried out in the conventional manner.
Results
Among a total of 31 consecutive dissections performed on 30 malignant melanoma patients between April 1999 and June 2002 neither intraoperative nor postoperative complications of the endoscopic part of the dissection were observed.
Conclusions
While enabling better local tumor control as a result of the complete dissection, this modification entailing the use of endoscopic pelvic dissection also appreciably reduces the extent of operative trauma without compromising oncological radicalness or increasing morbidity. We recommend this approach to all surgeons with experience with endoscopic extraperitoneal procedures for use in patients requiring inguinal dissection.
Similar content being viewed by others
References
Hughes TMD, Thomas JM (1999) Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg 86:1493–1498
Coit DG, Rogatko A, Brennan MF (1991) Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann Surg 214:627–636
Singletary SE, Shallenberger R, Guinee VF (1992) Surgical management of groin nodal metastases from primary melanoma of the lower extremity. Surg Gynecol Obstet 174:195–200
Mann GB, Coit DG (1999) Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol 6:263–271
Chan AD, Essner R, Wanek LA, Morton DL (2000) Judging the therapeutic value of lymph node dissection for melanoma. J Am Coll Surg 191:16–22
Coit DG, Rogatko A, Brennan MF (1991) Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. Ann Surg 214:627–636
Buzaid AC, Ross MI, Balch CM, Soong S, McCarthy WH, Tinoco L (1997) Critical analysis of the current American Joint Committee on cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 15:1039–1051
American Joint Committee on Cancer (1998) AJCC cancer staging handbook, 5th edn. Lippincott-Raven, Philadelphia
Sim FH, Taylor WF, Pritchard DJ, Soule EH (1986) Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomised study. Mayo Clin Proc 61:697–705
Sim FH, Nelson TE, Pritchard DJ (1997) Malignant melanoma: Mayo Clinic experience. Mayo Clin Proc 72:565–569
Balch CM, Soong SJ, Bartolucci AA (1996) Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224:255–266
Balch CM, Ross M, Soong SJ, Harrison R (1999) Long-term results of a prospective, randomised trial involving elective regional lymph node dissection in patients with intermediate thickness melanomas. In: Society of Surgical Oncology, 4–7 March 1999, Orlando
Veronesi U, Adamus J, Bandiera DC (1977) Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 297:627–638
Veronesi U, Adamus J, Bandiera DC (1982) Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49:2420–2430
Cascinelli N, Morabito A, Santinami M (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. WHO Melanoma Programme. Lancet 351:793–796
Lens MB, Dawes M, Goodacre T, Newton-Bishop JA (2002) Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomised controlled trials. Arch Surg 137:458–461
Joseph E, Brobeil A, Glass F, Glass J, Messina J, Der Conti R, Cruse CW, Rapaport DP, Berman C, Fenske N, Reintgen DS (1998) Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol 5:119–125
Albertini JJ, Cruse CW, Rapaport D (1996) Intraoperative radiolymphoscintigraphy improves sentinel node identification for patients with melanoma. Ann Surg 223:217–224
Morton DL, Wen DR, Wong JH (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399
Statius Muller MG, van Leeuwen Pam, de Lange-de Klerk ES (2001) The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 91:2401–2408
Chao C, Wong SL, Ross MI, Reintgen DS, et al (2002) Patterns of early recurrence after sentinel node biopsy for melanoma. Am J Surg 184:520–525
Strobbe LJA, Jonk A, Hart AAM, Nieweg OE, Kroon BBR (1999) Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol 6:255–262
Karakousis CP, Driscoll DL (1996) Positive deep nodes in the groin and survival in malignant melanoma. Am J Surg 171:421–422
Harman CR, Thompson JF, Bates D, Bartlett A (1997) Is iliac lymph node dissection of value? Melanoma Res 7 [Suppl 1]:S46–S47
Kissin MW, Simpson DA, Easton D, White H, Westbury G (1987) Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma. Br J Surg 74:1023–1026
Kretschmer L, Lautenschläger C, Preusser KP, Fiedler H (1993) Das inguinale Rezidiv nach therapeutischer Lymphadenektomie beim malignen Melanom. Langenbecks Arch Surg 378:211–216
Karakousis CP, Driscoll DL (1994) Groin dissection in malignant melanoma. Br J Surg 81:1771–1774
Beitsch P, Balch C (1992) Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg 164:462–466
Wexner SD, Cohen SM (1995) Port site metastases after laparoscopic colorectal surgery for cure of malignancy. Br J Surg 82:295–298
Schiedeck TH, Schwandner O, Baca I (2000) Laparoscopic surgery for the cure of colorectal cancer: results of a German five-center study. Dis Colon Rectum 43:1–8
Scheidbach H, Schneider C, Konrad J, Bärlehner E, Köhler L, Wittekind C, Köckerling F (2002) Laparoscopic abdominoperineal resection and anterior resection with curative intent for carcinoma of the rectum. Surg Endosc 16:7–13
Köckerling F, Reymond MA, Schneider C, Hohenberger W (1997) Fehler und Gefahren in der onkologischen laparoskopischen Chirurgie. Chirurg 68:215–224
Schneider C, Jung A, Reymond MA, Tannapfel A, Balli J, Franklin M, Hohenberger W, Köckerling F (2001) Efficacy of surgical measures in the prevention of port-site recurrences in a porcine model. Surg Endosc 15:121–125
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schneider, C., Brodersen, J.P., Scheuerlein, H. et al. Combined endoscopic and open inguinal dissection for malignant melanoma. Langenbecks Arch Surg 388, 42–47 (2003). https://doi.org/10.1007/s00423-003-0357-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-003-0357-7